Growth Metrics

Organon (OGN) Cost of Revenue (2020 - 2026)

Organon has reported Cost of Revenue over the past 7 years, most recently at $677.0 million for Q1 2026.

  • For Q1 2026, Cost of Revenue rose 0.74% year-over-year to $677.0 million; the TTM value through Mar 2026 reached $2.9 billion, up 7.9%, while the annual FY2025 figure was $2.9 billion, 8.0% up from the prior year.
  • Cost of Revenue for Q1 2026 was $677.0 million at Organon, down from $766.0 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $766.0 million in Q4 2025 and troughed at $551.0 million in Q3 2022.
  • A 5-year average of $651.6 million and a median of $665.0 million in 2024 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: fell 9.52% in 2022 and later grew 14.98% in 2023.
  • Year by year, Cost of Revenue stood at $594.0 million in 2022, then rose by 14.98% to $683.0 million in 2023, then rose by 1.9% to $696.0 million in 2024, then rose by 10.06% to $766.0 million in 2025, then dropped by 11.62% to $677.0 million in 2026.
  • Business Quant data shows Cost of Revenue for OGN at $677.0 million in Q1 2026, $766.0 million in Q4 2025, and $745.0 million in Q3 2025.